A HIGH THROUGH-PUT ASSAY FOR CIRCULATING ANTIBODIES DIRECTED AGAINST THE S PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)

BACKGROUND. More than one million infections with the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) have been confirmed. While PCR-based assays are used for diagnosis, high through-put serologic methods are needed to detect antibodies for seroserveillance and for identification of se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:medRxiv
Autors principals: Weiss, Svenja, Klingler, Jéromine, Hioe, Catarina, Amanat, Fatima, Baine, Ian, Kojic, Erna Milunka, Stoever, Jonathan, Liu, Sean, Jurczyszak, Denise, Bermudez-Gonzalez, Maria, Simon, Viviana, Krammer, Florian, Zolla-Pazner, Susan
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7276036/
https://ncbi.nlm.nih.gov/pubmed/32511609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.04.14.20059501
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars